Table 1.
Common antineoplastics tested in combination with heat.
Classification | Common name | Effect on cell cycle |
Mode of action | Synergy with heat |
Ref. |
---|---|---|---|---|---|
Platinum | Cisplatin Oxaliplatin Carboplatin |
G1/S | Formation of DNA adducts | More than additive | [121] |
Taxanes | Paclitaxel Docetaxel |
G2/M | Microtubule stabilization | Complex (depends on cell type) | [121] |
Campothecin | Irinotecan Topotecan |
S/G2 | Topoisomerase I inhibitor | [161] | |
Pyrimidine antagonists | 5-fluorouracil Cytarabine (Ara C) |
S | DNA inhibition | Independent | [81,115,118] |
Dihydropyrimidine dehydrogenase inhibitor | Gimeracil | S | Inhibits DNA double-strand break repair | [162] | |
Nucleoside analogs | Gemcitabine | S | DNA inhibition | [132,133,163,144] | |
Alkylating agents | Cyclophosphamide Mephalan Ifosfamide Mitomycin C |
G1/S | Incorporates an alkyl group to DNA guanine’s bases | More than additive | [81,118] |
Vinca alcaloids | Vincristin Vinblastine |
M | Mitotic inhibitor that prevents microtubule assembly | Independent | [121] |
Proteasome inhibitors | Bortezomib | G2/M | Binds to 26S proteasome | More than additive | [126,127,164] |
ROS-generating species | Tert-butyl hydroperoxide | S | More than additive | [165–167] | |
Heat shock protein Inhibitors | Geldanamycin Flavonoids Tanespimycin |
Effect on G1 and G2 checkpoint proteins | Decrease in the amount of checkpoint proteins produced | More than additive | [129,134–136] |
PARP-1 inhibitors | NU1025 PJ-34 |
S | Repair inhibition of single-strand breaks | [168] | |
Antibiotics | Bleomycin Doxorubicin Actinomycin D |
Breaks DNA DNA intercalation DNA transcription inhibitor | Complex | [81,118] |
ROS: Reactive oxygen species.